extensive customization of the Company's software and IT systems. In July 2012, the enhanced IT platform became operational. Although the Company has been encouraged by its experience with the enhanced platform during the first few months of the platform's start-up phase, there can be no assurance that, during the remainder of this start-up phase, the new platform will continue to maintain its functionality at the levels anticipated or otherwise meet the Company's business and operational objectives. If unforeseen problems arise, the Company's operations could be adversely impacted, including the ability of the Company to perform one or more of the following in a timely manner: customer quotes, customer orders, product shipment, customer services and support, order billing and tracking, contractual obligations fulfillment and related operations. As previously disclosed, the Company expects to incur ongoing maintenance expenditures for the new IT platform at levels higher than the Company traditionally experienced under its prior platform. Unforeseen problems with the new platform could increase further such expenditures.
Financial Tables Follow
Landauer, Inc. and Subsidiaries First Fiscal Quarter 2013 Consolidated Statements of Income (Unaudited)Three Months EndedDecember 31,(Dollars in Thousands, Except per Share)20122011Net revenues
36,669Costs and expenses:Cost of sales16,56314,906Selling, general and administrative13,39112,361Acquisition and reorganization costs01,849Costs and expenses29,95429,116Operating income6,7277,553Equity in income of joint ventures1,528804Interest income (expense), net(1,033)(590)Other income (expense), net9559Income before taxes7,3177,826Income taxes2,2742,742Net income5,0435,084Less: Net income attributed to noncontrolling interest166159Net income attributed to Landauer, Inc.
4,925Net income perPage: 1 2 3 4 5 6 7 8 9 10 11 Related medicine technology :1
. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results2
. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results3
. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer4
. Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement5
. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results6
. Allied Healthcare Products Reports Second Quarter Loss7
. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com8
. Pharmaceutical Market & Biotechnology Industry 2013 Outlook in New Research Reports at ReportsnReports.com9
. Misonix Reports Financial Results for First Half of Fiscal 201310
. CareFusion Reports First Half Fiscal 2013 Results11
. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results